# Vitamin C Immune Support Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-c-immune-support-meta-analysis-evidence-review
Category: evidence-review
Summary: Vitamin C Immune Support Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-26
Reviewed by: Migaku Evidence Review
# Vitamin C Immune Support Meta-analysis: What the Evidence Says

## Quick Answer

Vitamin C Immune Support Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of micronutrient supplementation on immune function in older adults: a meta-analysis. | systematic review | 1 | 2026-05-22 | 10.3389/fimmu.2026.1732861 |
| The Influence of Vitamin C on Stromal and Epithelial Cells of the Pancreas in Malignant and Benign/Inflammatory Pancreatic Diseases: Protocol for a Scoping Review. | preclinical study | 4 | 2026-06-22 | 10.2196/91522 |

## What The Sources Report

- Risk of bias was assessed using the Cochrane ROB2 tool, and meta-analysis was conducted using a random-effects model. [Li D (2026); evidence level 1]
- Background Micronutrient deficiencies are common in the older adults and exacerbate these changes. [Li D (2026); evidence level 1]
- In accordance with the PRISMA-ScR recommendations, a formal risk-of-bias assessment will not be performed. [Plischke H (2026); evidence level 4]
- Background With a 5-year survival rate of less than 10% in most regions worldwide, pancreatic ductal adenocarcinoma (PDAC) has been considered as one of the deadliest tumor diseases. [Plischke H (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin c immune support meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Li D (2026). Effects of micronutrient supplementation on immune function in older adults: a meta-analysis.. DOI: 10.3389/fimmu.2026.1732861. PMCID: PMC13236568. PMID: 42254024. https://pmc.ncbi.nlm.nih.gov/articles/PMC13236568/
- Plischke H (2026). The Influence of Vitamin C on Stromal and Epithelial Cells of the Pancreas in Malignant and Benign/Inflammatory Pancreatic Diseases: Protocol for a Scoping Review.. DOI: 10.2196/91522. PMCID: PMC13286521. PMID: 42330555. https://pmc.ncbi.nlm.nih.gov/articles/PMC13286521/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.